The DOI matches its Crossref record.
Two-Week Dietary Soy Supplementation Has an Estrogenic Effect on Normal Premenopausal Breast
Abstract
Introduction: Isoflavones are hypothesized to protect against breast cancer, but it is not clear whether they act as oestrogens or anti-oestrogens in breast tissue.Our aim was to determine the effects of taking a red clover-derived isoflavone supplement daily for 1 year on mammographic breast density.Effects on oestradiol, follicle-stimulating hormone (FSH), luteinizing hormone (LH), lymphocyte tyrosine kinase activity and menopausal symptoms were also assessed.Methods: A total of 205 women (age range 49-65 years) with Wolfe P2 or DY mammographic breast patterns were randomly assigned to receive either a red clover-derived isoflavone tablet (26 mg biochanin A, 16 mg formononetin, 1 mg genistein and 0.5 mg daidzein) or placebo.Change in mammographic breast density, serum oestradiol, FSH, LH, menopausal symptoms and lymphocyte tyrosine kinase activity from baseline to 12 months were assessed.Results: A total of 177 women completed the trial.Mammographic breast density decreased in both groups but the difference between the treatment and placebo was not statistically significant.There was a significant interaction between treatment group and oestrogen receptor (ESR1) PvuII polymorphism for the change in estimated percentage breast density (mean ± standard deviation): TT isoflavone 1.4 ± 12.3% and TT placebo -9.6 ± 14.2%; CT isoflavone -5.2 ± 12.0% and CT placebo -2.8 ± 10.3%; and CC isoflavone -3.4 ± 9.7% and CC placebo -1.1 ± 9.5%.There were no statistically significant treatment effects on oestradiol, FSH, or LH (assessed only in postmenopausal women), or on lymphocyte tyrosine kinase activity.Baseline levels of menopausal symptoms were low, and there were no statistically significant treatment effects on frequency of hot flushes or other menopausal symptoms. Conclusion:In contrast to studies showing that conventional hormone replacement therapies increase mammographic breast density, the isoflavone supplement did not increase mammographic breast density in this population of women.Furthermore, there were no effects on oestradiol, gonadotrophins, lymphocyte tyrosine kinase activity, or menopausal symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Genistein and Cancer: Current Status, Challenges, and Future Directions
Spagnuolo, C., Russo, G. L., Orhan, I. E., Habtemariam, S., Daglia, M., Sureda, A., Nabavi, S. F., Devi, K. P., Loizzo, M. R., Tundis, R., et al. (2015) · Advances in Nutrition · doi:10.3945/an.114.008052 · Cited by 557
Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature
Messina, M. (2016) · Nutrients · doi:10.3390/nu8120754 · Cited by 537
Soy, Soy Foods and Their Role in Vegetarian Diets
Rizzo, G., & Baroni, L. (2018) · Nutrients · doi:10.3390/nu10010043 · Cited by 498
The potential health effects of dietary phytoestrogens
Rietjens, I. M. C. M., Louisse, J., & Beekmann, K. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13622 · Cited by 490
Phytoestrogens: a review of the present state of research
Ososki, A. L., & Kennelly, E. J. (2003) · Phytotherapy Research · doi:10.1002/ptr.1364 · Cited by 479
Herbal Remedies in the United States: Potential Adverse Interactions With Anticancer Agents
Sparreboom, A., Cox, M. C., Acharya, M. R., & Figg, W. D. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.182 · Cited by 473
Soy for Breast Cancer Survivors: A Critical Review of the Literature
Messina, M. J., & Loprinzi, C. L. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.11.3095s · Cited by 359
Flavonoids and Cancer Prevention: A Review of the Evidence
Romagnolo, D. F., & Selmin, O. I. (2012) · Journal of Nutrition in Gerontology and Geriatrics · doi:10.1080/21551197.2012.702534 · Cited by 354
Magee, P. J., & Rowland, I. R. (2004) · British Journal of Nutrition · doi:10.1079/bjn20031075 · Cited by 342
Addressing the Soy and Breast Cancer Relationship: Review, Commentary, and Workshop Proceedings
Messina, M., McCaskill-Stevens, W., & Lampe, J. W. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj356 · Cited by 308
Ju, Y. H., Allred, C. D., Allred, K. F., Karko, K. L., Doerge, D. R., & Helferich, W. G. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.11.2957 · Cited by 274
Bioavailability and Pharmacokinetics of Genistein: Mechanistic Studies on its ADME
Yang, Z., Kulkarni, K., Zhu, W., & Hu, M. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012803833107 · Cited by 270
Soy Isoflavones: a Safety Review
Munro, I. C., Harwood, M., Hlywka, J. J., Stephen, A. M., Doull, J., Flamm, W. G., & Adlercreutz, H. (2003) · Nutrition Reviews · doi:10.1301/nr.2003.janr.1-33 · Cited by 265
Polyphenols as dietary supplements: A double-edged sword
Martin, K. R. (2009) · Nutrition and Dietary Supplements · doi:10.2147/nds.s6422 · Cited by 265
Grace, P. B., Taylor, J. I., Low, Y.-L., Luben, R. N., Mulligan, A. A., Botting, N. P., Dowsett, M., Welch, A. A., Khaw, K.-T., Wareham, N. J., et al. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.698.13.5 · Cited by 264
Isoflavonoid and Lignan Phytoestrogens as Dietary Biomarkers
Lampe, J. W. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.3.956s · Cited by 261
Lee, S.-A., Shu, X.-O., Li, H., Yang, G., Cai, H., Wen, W., Ji, B.-T., Gao, J., Gao, Y.-T., & Zheng, W. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27361 · Cited by 224
Soy Isoflavone Supplementation for Breast Cancer Risk Reduction: A Randomized Phase II Trial
Khan, S. A., Chatterton, R. T., Michel, N., Bryk, M., Lee, O., Ivancic, D., Heinz, R., Zalles, C. M., Helenowski, I. B., Jovanovic, B. D., et al. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0251 · Cited by 175
Atkinson, C., Warren, R. M., Sala, E., Dowsett, M., Dunning, A. M., Healey, C. S., Runswick, S., Day, N. E., & Bingham, S. A. (2004) · Breast Cancer Research · doi:10.1186/bcr773 · Cited by 151
Perspectives on the soy-breast cancer relation
Messina, M., & Wu, A. H. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.26736v · Cited by 113
A 2-year soy intervention in premenopausal women does not change mammographic densities
Maskarinec, G., Takata, Y., Franke, A. A., Williams, A. E., & Murphy, S. P. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.11.3089 · Cited by 112
The specific role of isoflavones on estrogen metabolism in premenopausal women
Kumar, N. B., Cantor, A., Allen, K., Riccardi, D., & Cox, C. E. (2002) · Cancer · doi:10.1002/cncr.10320 · Cited by 105
Touillaud, M. S., Pillow, P. C., Jakovljevic, J., Bondy, M. L., Singletary, S. E., Li, D., & Chang, S. (2005) · Nutrition and Cancer · doi:10.1207/s15327914nc5102_6 · Cited by 68
Nishio, K., Niwa, Y., Toyoshima, H., Tamakoshi, K., Kondo, T., Yatsuya, H., Yamamoto, A., Suzuki, S., Tokudome, S., Lin, Y., et al. (2007) · Cancer Causes & Control · doi:10.1007/s10552-007-9023-7 · Cited by 63
Soy consumption and histopathologic markers in breast tissue using tissue microarrays
Maskarinec, G., Erber, E., Verheus, M., Hernandez, B. Y., Killeen, J., Cashin, S., & Cline, J. M. (2009) · Nutrition and Cancer · doi:10.1080/01635580902913047 · Cited by 17
Metadata
- Authors
- Hargreaves, D. F.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-11-01
- Volume
- 84
- Issue
- 11
- Pages
- 4017-4024
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W3144493907
- Cited by
- 169
- References
- 0
- FWCI
- 6.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.